Welcome to the current edition of i2P (Information to Pharmacists) E-Magazine dated Monday 2 April, 2018.
It was heartening to see TV images of US students and their supporters turning out for mass demonstrations to highlight the need to reform their country’s gun ownership laws in a bid to save their own future lives.
Gun manufacturers have an extraordinary control over US legislators, very similar to that of drug manufacturers.
Many of these demonstrating students are too young to vote in general elections currently, so there may still be delays and “foot-dragging” in passing the necessary enabling legislation.
But there is no doubt that the US political system is now on notice to reform, because these students have created a global movement that will prove unstoppable, particularly when they become eligible to vote in a few short years.
So there is some hope that as they deal with their immediate issues surrounding gun control they may use this new infrastructure and turn their attention to other weapons of mass destruction.
Specifically I refer to vaccine manufacturers, who systematically continue to manufacture vaccines not based on appropriate science, and continue to damage children and adults with products that are simply not safe.
While the vaccine debate is orchestrated to illustrate only two sides – for and against vaccination, there is a third side.
That is for safe vaccination and i2P’s own investigations indicate that vaccines are anything but safe.
i2P supports the principle of vaccination, but with safe vaccines accompanied by a freedom to choose for yourself.
What we have in Australia is simply a violation of human rights.
Australia, under the Turnbull government, is still pursuing international trade treaties.
These treaties openly favour global corporates at the expense of the taxpayers of the countries involved.
Global companies are empowered under these trade treaties to sue sovereign governments for losses that may be incurred by these companies due to legislation that may be enacted by democratically elected governments of the involved countries.
There are other treaty formats where global corporates also hold sway, and they involve United Nations Organisation governance.
This explains how sovereign government policy is manipulated, often overruled by faceless people hiding in boardrooms around the world.
One such example involves the suppression of medical cannabis.
It is also part of the blueprint for a one world government ruled by a coalition of global corporate entities.
The United Nations International Narcotics Control Board (INCB) recently issued its 2017 annual report, and the takeaway with regard to cannabis is clear:
The INCB is deeply concerned with the spread of adult-use legalisation of cannabis.
Countries pursuing legalisation are acting in “clear violation” of the UN’s 1961 Single Convention on Narcotic Drugs, says the International Narcotics Control Board.
It would seem that a revision of this convention is long overdue, because it delivers unusual power to a small group of people.
The INCB report contains stern warnings, accusing countries like Uruguay of acting in “clear violation” of global drug control accords.
The Board, which monitors compliance with international drug control treaties, is made up of individuals, not U.N. member states.
That’s meant to protect it from political pressure.
How undemocratic and manipulative a control practice is that!
The Board’s charter also stipulates, however, that it must include individuals with “medical, pharmacological or pharmaceutical experience.”
That means Big Pharma is well represented, while advocates for cannabis legalisation—whether medical or adult-use—have no seat at the table.
International drug control treaties, signed by most member states decades ago, are meant to prohibit the proliferation and non-medical use of of dangerous drugs.
Cannabis is specifically covered under most of the treaties.
But cannabis has a low toxicity (there has never been a single death recorded for the use of cannabis as a single agent) and does not create addiction.
Moreover, it has been found to have a range of beneficial (for human health) properties.
In this instance we are referring to the natural plant product.
Synthesised versions come with a range of side-effects.
But in recent years, countries like Uruguay have legalised and regulated the non-medical use of cannabis.
Canada is planning to legalise later this year.
In the United States, nine states and the District of Columbia have implemented some form of adult-use legalisation.
Australia is moving towards legalisation for medical cannabis, but in an extremely confusing and manipulative manner, creating access difficulties.
That suggests other pressures may be involved.
Legalisation of cannabis does not sit well with the INCB.
“Governments and jurisdictions in North America have continued to pursue policies with respect to the legalisation of the use of cannabis for non-medical purposes, in violation of the 1961 Convention as amended,” states the Board’s 2017 report.
It would seem that Australia needs to negotiate a more open position with the INCB so that the benefits of medical cannabis can begin to properly flow.
And the control by global drug companies needs to be broken!
The lead article in this edition gives background as to what has really happened to all delivery formats of health.
It is said that “money is the root of all evil” and it is certainly the motivating force that drives most aspects of global health issues.
But the word “health” has now taken on a more narrow meaning to that of “illness management”.
There has been a constant strategy involving the provision of drugs-only solutions for all labelled medical conditions – even to the extent of inventing and labelling a subset of symptoms as an illness, with of course, only a drug solution.
That this strategy has been developed into a major global orchestration involving manipulation of sovereign governments through personal and political party “donations” and the development of a treaty system that bypasses democratic laws developed within individual countries, ranging to a “take no prisoners” war, where allopathic medicine tries to kill off all other forms of health practice through tactics that resemble those of the Mafia of the 1920’s.
Our democratic systems are failing us and we are failing future generations by not standing up to corruption and fraudulent misuse of health systems.
Read: What Underwrites the Phenomenon of Illness Marketing
Gerald Quigley is back and discusses an aspect of patient engagement that is not an acceptable component of pharmacy practice.
There is definitely an impact by communication technology devices on basic human communication.
You can see it in many professional patient engagements as well as in private settings.
For example, the dinner table, the traditional method for families to interact with each other informatively and exchange aspects of daily events is often now a silent event as each family member accesses their smart phone.
And, heaven forbid, even text another family member at the same table!
Patients react with health professionals who take a genuine interest in them and all successful health professionals engage with their patients without impediment or interruption.
It has to be Rule #1 in your patient engagement handbook.
Read: Have we lost our therapeutic gaze?
Jon Rappoport is a very aware US-based investigative journalist and is able to give an insider’s view as to what is really happening in the world outside our own limited view.
He explores the issues of misuse of power and how positive science can be subverted for the benefit of a few wealthy global corporates.
In this instance he gives a different perspective to the Internet and perhaps why the Australian government is developing a very expensive and problem-ridden National Broadband Network (NBN) at considerable taxpayer cost.
The question is, will it be for taxpayer benefit or will it extend an undemocratic elite power base that virtually enslaves all of its citizens?
Read: The Internet of Things: a game for morons and control freaks
Dr Ralph Campbell MD has written an article on sore throats – a common presentation in a community pharmacy setting.
He describes the various forms and integrative treatments for these conditions.
Clinical nutrition therapy provides an alternative and safe approach in the treatment of sore throat and assists the body to repair itself and is certainly an option in these days of antibiotic avoidance prescribing.
Read: OMNS- SORE THROAT- Effective treatment means more vitamins, fewer drugs
“The science is settled”.
So say the people who promote vaccination as some form of extreme medical ideology.
“Scientism is settled” is a more accurate description of the manipulation of the science surrounding vaccines – and it is certainly “unsettling” to hear the dishonest claims that blare out in all forms of media.
“First do no harm” is the concept that underwrites all medical practice.
Australian vaccination policy is so poor and damaging, that it beggars belief that legislators can be so close to manufacturer sales objectives as to guarantee them a market through coercive legislation that involves simultaneous removal of patient choice.
The evidence supporting vaccine policy failure and its lack of safety is becoming so voluminous that it will eventually destroy the unnatural power alliance that desperately tries to hold it all together.
Read: The Safe Vaccine Debate – 1. Robert Kennedy’s World Mercury Project: Yeast in Vaccines Tied to Autoimmune Diseases 2. Dr Judy Wilyman Report: Newsletter #195 Vaccines and Medical Freedom in Australia 3. NVIC – Prepare For Change: How Vaccinated Kids Infect The Non-Vaccinated
WHO has made a statement saying that cannabis should be decriminalised world-wide because existing laws cause health discrimination.
In Australia, patients are being actively discriminated against as police are instructed to enforce existing laws and close down “illegal” supplies, leaving critically ill people with no workable solutions for their health problems.
Flawed health policy generates bad laws and lowered community respect for policy and laws.
Yet again, Pharmacy is in a position to provide solutions very simply and simultaneously create opportunity for the profession to treat chronically ill patients efficiently and economically.
Pharmacy leaders need to be proactive in the regulatory area because other health professionals are actively competing to lock pharmacy out of any opportunity whatsoever.
Potential for pharmacists is found in the compounding of THC and CBD in specific ratios to match the best result for patients with chronic illness.
Further pharmacist potential also lies in using cannabinoids in harm minimisation programs involving opioid dependencies and as an adjunct for the management of pain.
Pharmacists also need to be active and have a voice in the regulation of these substances ensuring that maximum patient access can be obtained through the application of Schedule 3 of the Poison’s Act.
Read: Understanding Medical Cannabis – 1. ABC News: Brisbane father blames barriers to cannabis oil for daughter’s death 2. BuzzFeed News: This Professor Wrote There Was No Evidence For Using Cannabinoids For Pain. Then He Said The Opposite 3. MedicalXpress: Medicinal cannabis is safe and effective—it’s time to reboot research
Harvey Mackay is back with an article on perseverance.
Perseverance is the quality that underwrites success.
It is the magic ingredient that reinforces a direction when a necessary change is required to adapt your professional practice to satisfy a community need. You can think through appropriate changes and rationalise them to yourself – even design and record a range of micro-processes to achieve a change.
But it has to be successful change and perseverance is the factor that drives and moderates the entire process.
Read: Perseverance pays off
And we conclude our offering for this edition with media releases from two pharmacy leadership organisations:
NPS – NPS Media Releases – 1. Pharmacy Practice Review – Statins: promoting adherence, addressing intolerance 2. Fast Five Rheumatoid Arthritis 3. NMS early bird registration now open 4. Winners of our National ‘Preserve the Power’ Competition 5. Australian Prescriber
We hope that you enjoy the content of this edition and encourage you to become part of the debate by adding your comments in the panel provided at the foot of each article.
Editor i2P E-Magazine
Monday 2 April 2018